Cargando…

Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation

BACKGROUND: The oncogenic transcription factor MYC is pathologically activated in many human malignancies. A paradigm for MYC dysregulation is offered by Burkitt lymphoma, where chromosomal translocations leading to Immunoglobulin gene-MYC fusion are the crucial initiating oncogenic events. However,...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Falco, Giulia, Ambrosio, Maria Raffaella, Fuligni, Fabio, Onnis, Anna, Bellan, Cristiana, Rocca, Bruno Jim, Navari, Mohsen, Etebari, Maryam, Mundo, Lucia, Gazaneo, Sara, Facchetti, Fabio, Pileri, Stefano A., Leoncini, Lorenzo, Piccaluga, Pier Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600215/ https://www.ncbi.nlm.nih.gov/pubmed/26453442 http://dx.doi.org/10.1186/s12885-015-1661-7

Ejemplares similares

Alteration of MicroRNAs Regulated by c-Myc in Burkitt Lymphoma
por: Onnis, Anna, et al.
Publicado: (2010)

Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma
por: Abate, Francesco, et al.
Publicado: (2015)

Molecular switch from MYC to MYCN expression in MYC protein negative Burkitt lymphoma cases
por: Mundo, Lucia, et al.
Publicado: (2019)

Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas
por: Piccaluga, Pier Paolo, et al.
Publicado: (2015)

Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus
por: Navari, Mohsen, et al.
Publicado: (2014)

The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma
por: Navari, Mohsen, et al.
Publicado: (2015)

Unveiling Another Missing Piece in EBV-Driven Lymphomagenesis: EBV-Encoded MicroRNAs Expression in EBER-Negative Burkitt Lymphoma Cases
por: Mundo, Lucia, et al.
Publicado: (2017)

The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma
por: Ambrosio, Maria Raffaella, et al.
Publicado: (2014)

Clonality Analysis of Immunoglobulin Gene Rearrangement by Next-Generation Sequencing in Endemic Burkitt Lymphoma Suggests Antigen Drive Activation of BCR as Opposed to Sporadic Burkitt Lymphoma
por: Amato, Teresa, et al.
Publicado: (2016)

Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt Lymphoma
por: Bagaloni, Irene, et al.
Publicado: (2021)

HIV-1 Tat induces DNMT over-expression through microRNA dysregulation in HIV-related non Hodgkin lymphomas
por: Luzzi, Anna, et al.
Publicado: (2014)

Improvement of diagnosis in children with Burkitt lymphoma in Kenya: feasibility study for the implementation of fluorescence in situ hybridisation testing for MYC and the MYC/IGH translocation
por: Vance, Gail H, et al.
Publicado: (2023)

The Alteration of Lipid Metabolism in Burkitt Lymphoma Identifies a Novel Marker: Adipophilin
por: Ambrosio, Maria R., et al.
Publicado: (2012)

Pathobiologic Roles of Epstein–Barr Virus-Encoded MicroRNAs in Human Lymphomas
por: Navari, Mohsen, et al.
Publicado: (2018)

Epstein-Barr nuclear antigen 1 induces expression of the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphoma
por: Onnis, A, et al.
Publicado: (2012)

Enhancer RNA AL928768.3 from the IGH Locus Regulates MYC Expression and Controls the Proliferation and Chemoresistance of Burkitt Lymphoma Cells with IGH/MYC Translocation
por: Stasevich, Ekaterina Mikhailovna, et al.
Publicado: (2022)

Use of Next Generation Sequencing to Define the Origin of Primary Myelofibrosis
por: Visani, Giuseppe, et al.
Publicado: (2023)

Deep Sequencing of MYC DNA-Binding Sites in Burkitt Lymphoma
por: Seitz, Volkhard, et al.
Publicado: (2011)

Developments in Burkitt’s lymphoma: novel cooperations in oncogenic MYC signaling
por: Spender, Lindsay C, et al.
Publicado: (2014)

MicroRNAs sequencing unveils distinct molecular subgroups of plasmablastic lymphoma
por: Ambrosio, Maria Raffaella, et al.
Publicado: (2017)

The 11q-Gain/Loss Aberration Occurs Recurrently in MYC-Negative Burkitt-like Lymphoma With 11q Aberration, as Well as MYC-Positive Burkitt Lymphoma and MYC-Positive High-Grade B-Cell Lymphoma, NOS
por: Grygalewicz, Beata, et al.
Publicado: (2018)

Targeting the MYC Oncogene in Burkitt Lymphoma through HSP90 Inhibition
por: Poole, Candace J., et al.
Publicado: (2018)

SNPs Array Karyotyping in Non-Hodgkin Lymphoma
por: Etebari, Maryam, et al.
Publicado: (2015)

Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma
por: Ferreri, Andrés J.M., et al.
Publicado: (2022)

MYC chromosomal aberration in differential diagnosis between Burkitt and other aggressive lymphomas
por: Aquino, Gabriella, et al.
Publicado: (2013)

Tuberous sclerosis complex is required for tumor maintenance in MYC‐driven Burkitt's lymphoma
por: Hartleben, Götz, et al.
Publicado: (2018)

Cryptic MYC insertions in Burkitt lymphoma: New data and a review of the literature
por: Woroniecka, Renata, et al.
Publicado: (2022)

The CT-Element of The C-Myc Gene Does Not Predispose to Chromosomal Breakpoints in Burkitt'S Lymphoma
por: Weber, Achim, et al.
Publicado: (2006)

Genetic features of precursor B‐cell phenotype Burkitt leukemia with IGH‐ MYC rearrangement
por: Yoshida, Masanori, et al.
Publicado: (2021)

Epstein–Barr virus reactivation influences clonal evolution in human herpesvirus‐8‐related lymphoproliferative disorders
por: Granai, Massimo, et al.
Publicado: (2021)

Burkitt lymphomagenesis linked to MYC plus PI3K in germinal center B cells
por: Sander, Sandrine, et al.
Publicado: (2012)

How does Epstein–Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?
por: Allday, Martin J.
Publicado: (2009)

Molecular mechanism of c‐Myc and PRPS1/2 against thiopurine resistance in Burkitt's lymphoma
por: Li, Ting, et al.
Publicado: (2020)

Protein kinase CK2 is widely expressed in follicular, Burkitt and diffuse large B-cell lymphomas and propels malignant B-cell growth
por: Pizzi, Marco, et al.
Publicado: (2015)

C-myc and N-myc in the developing brain
por: Wey, Alice, et al.
Publicado: (2010)

MYC Immunohistochemistry Predicts MYC Rearrangements by FISH
por: Nwanze, Julum, et al.
Publicado: (2017)

New MYC IHC Classifier Integrating Quantitative Architecture Parameters to Predict MYC Gene Translocation in Diffuse Large B-Cell Lymphoma
por: Bigras, Gilbert, et al.
Publicado: (2018)

Value of CD44 immunostaining (IHC) as a surrogate in the differentiation of MYC-positive Burkitt lymphoma (BL) and Burkitt lymphoma-like (BLL) from MYC-negative Diffuse Large B-Cell Lymphoma (DLBCL) in a resource constrained clinical setting
por: Ayers, LW, et al.
Publicado: (2009)

Role of protein arginine methyltransferase 5 in group 3 (MYC-driven) Medulloblastoma
por: Chaturvedi, Nagendra K., et al.
Publicado: (2019)

The Molecular ‘Myc-anisms’ Behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics
por: McAnulty, Jessica, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2v2r4ptc87rassou51264j4hd1